Cargando…
Interleukin-35 is associated with the tumorigenesis and progression of prostate cancer
Interleukin (IL)-35 is a novel member of the IL-12 cytokine family, which exhibits a unique immune regulatory function. Previously, it was demonstrated that IL-35 expression is significantly increased in a wide range of tumor tissues, promoting angiogenesis and inhibiting the anti-tumor immune respo...
Autores principales: | Zhu, Jialin, Yang, Xueling, Wang, Yan, Zhang, Haonan, Guo, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507472/ https://www.ncbi.nlm.nih.gov/pubmed/31186721 http://dx.doi.org/10.3892/ol.2019.10208 |
Ejemplares similares
-
Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
por: Zhu, Jialin, et al.
Publicado: (2020) -
Interleukin-35 expression is associated with colon cancer progression
por: Zhang, Jian, et al.
Publicado: (2017) -
Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy
por: Zhou, Chenchao, et al.
Publicado: (2017) -
Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese
por: Liu, Jie, et al.
Publicado: (2010) -
Deubiquitinase USP35 stabilizes BRPF1 to activate mevalonate (MVA) metabolism during prostate tumorigenesis
por: Lin, Guowen, et al.
Publicado: (2022)